Clinical trial reports

  • What Shapes EU Phase I Rare Disease CTIS Timelines and Delays?
  • Which CROs Support European Phase III Immunology Trials Most, and When Are They Needed?
  • How Fast Are EU Phase II Haematology CTIS Reviews and What Delays Them?
  • Which CROs Support Alzheimer’s Phase II & III Trials in Europe, and Where Is Demand Highest?
  • Which Endpoints Are Measured Most Often in European Phase II & III Lung Cancer Trials?
  • Where Are CROs Most Active in European Infectious Disease Phase 3 Trials?
  • Which EU Sites Anchor Phase II–III Prostate Cancer Trial Activity?
  • OS vs PFS as Primary Endpoints in Phase III Colorectal Cancer Trials
  • Oncology Phase III Endpoint Architecture, 2024–2026
  • Which European Sites Lead Phase III Cell Therapy Trial Activity in CTIS?
  • How Long Do Phase III Rare Disease CTIS Reviews Take and What Shapes Delay?
  • Which Endpoints Are Measured Most Often in European Leukemia Phase II & III Trials?